X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3) 3
inhibition (3) 3
animals (2) 2
anticarcinogenic agents - pharmacology (2) 2
anticarcinogenic agents - therapeutic use (2) 2
arrestin (2) 2
breast-cancer (2) 2
cancer (2) 2
carcinogenesis - drug effects (2) 2
epidermal growth factor (2) 2
epidermal growth factor - metabolism (2) 2
hek293 cells (2) 2
humans (2) 2
mice (2) 2
oncology (2) 2
population-based cohort (2) 2
prevention (2) 2
skin (2) 2
transformation (2) 2
ablation (1) 1
activation (1) 1
activator protein-1 (1) 1
administration, cutaneous (1) 1
adrenergic beta-antagonists - pharmacology (1) 1
adrenergic beta-antagonists - therapeutic use (1) 1
adrenergic receptors (1) 1
alprenolol (1) 1
animal models (1) 1
antagonists (1) 1
antibodies (1) 1
anticancer properties (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antioxidant (1) 1
antitumor activity (1) 1
asthma (1) 1
beta-adrenoceptor antagonist (1) 1
beta-blocker use (1) 1
beta-blockers (1) 1
biased -blocker (1) 1
biased β-blocker (1) 1
biased β‐blocker (1) 1
binding (1) 1
biochemistry & molecular biology (1) 1
biocompatibility (1) 1
biology and life sciences (1) 1
blocker (1) 1
blocker use (1) 1
c-jun (1) 1
cancer-cells (1) 1
cancer-specific survival (1) 1
carbazoles - pharmacology (1) 1
carbazoles - therapeutic use (1) 1
carcinogenesis (1) 1
carcinogenesis - metabolism (1) 1
carcinogenesis - pathology (1) 1
carcinogenesis - radiation effects (1) 1
carcinogens (1) 1
carvedilol - pharmacology (1) 1
carvedilol - therapeutic use (1) 1
cell transformation, neoplastic - drug effects (1) 1
cell transformation, neoplastic - metabolism (1) 1
cell transformation, neoplastic - radiation effects (1) 1
chemotherapy (1) 1
cyclic-amp accumulation (1) 1
cytotoxicity (1) 1
disease models, animal (1) 1
disease prevention (1) 1
dna-damage (1) 1
elk (1) 1
engineering and technology (1) 1
epidermis - cytology (1) 1
epidermis - drug effects (1) 1
epidermis - pathology (1) 1
epidermis - radiation effects (1) 1
extracellular signal-regulated kinase (1) 1
female (1) 1
fractionation (1) 1
growth factors (1) 1
health aspects (1) 1
health sciences (1) 1
hypotheses (1) 1
inverse agonists (1) 1
isoproterenol (1) 1
jb6 cells (1) 1
jb6 p+ cells (1) 1
kappa-b (1) 1
keratinocytes - drug effects (1) 1
keratinocytes - metabolism (1) 1
keratinocytes - radiation effects (1) 1
ligands (1) 1
male (1) 1
medicine (1) 1
medicine and health sciences (1) 1
melanoma (1) 1
melanoma - metabolism (1) 1
melanoma - pathology (1) 1
melanoma - prevention & control (1) 1
mice, hairless (1) 1
mice, inbred nod (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, 2019, Volume 14, Issue 5, p. e0217038
Carvedilol is reported to prevent cancers in humans and animal models. However, a molecular mechanism has yet to be established, and the extent to which other... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 2617 - 2617
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14_Supplement, pp. 2617 - 2617
The response to ultraviolet (UV) radiation is the primary etiologic factor leading to carcinogenesis of the skin. The effects of UV radiation on the skin is... 
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 1915 - 1915
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 08/2018, Volume 57, Issue 8, pp. 997 - 1007
Recent studies suggest that the β‐blocker drug carvedilol prevents skin carcinogenesis but the mechanism is unknown. Carvedilol is one of a few β‐blockers... 
alprenolol | biased β‐blocker | carcinogenesis | β‐blocker | JB6 P+ cells | β-blocker | biased β-blocker | SURVIVAL | blocker | ACTIVATION | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | BREAST-CANCER | THERAPY | ONCOLOGY | PATHWAY | POPULATION-BASED COHORT | biased -blocker | C-JUN | BETA-BLOCKER USE | JB6 CELLS | Melanoma - metabolism | Humans | Carvedilol - pharmacology | Epidermal Growth Factor - metabolism | Male | Melanoma - pathology | Mice, SCID | Carcinogenesis - metabolism | Carcinogenesis - drug effects | Carcinogenesis - pathology | Adrenergic beta-Antagonists - pharmacology | Animals | Melanoma - prevention & control | Mitogen-Activated Protein Kinase 3 - metabolism | Proto-Oncogene Proteins c-jun - metabolism | HEK293 Cells | Mice, Inbred NOD | Phosphorylation - drug effects | Carvedilol - therapeutic use | Anticarcinogenic Agents - pharmacology | Proteome - metabolism | Adrenergic beta-Antagonists - therapeutic use | Anticarcinogenic Agents - therapeutic use | Mitogen-Activated Protein Kinase 1 - metabolism | Prevention | Epidermal growth factor | Cancer | Translocation | Phosphorylation | Fractionation | Transformation | Elk | Xenotransplantation | Melanoma | Antibodies | Extracellular signal-regulated kinase | Arrestin | Carcinogenesis | Nuclear transport | Anticancer properties | Ribosomal protein S6 kinase | Signaling | Carcinogens | Xenografts | Antitumor activity | Skin | Inhibition | Index Medicus
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 10/2017, Volume 10, Issue 10, pp. 598 - 606
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.